GSE131984

syn77079864

Created By Aditya Nath aditya.nath

doi: 10.1038/s41467-020-16170-3
title: Acquired resistance to combined BET and CDK4/6 inhibition in triple-negative breast cancer [scRNA-Seq]
funder: NIH-NCI
series:
creator: Ge Jennifer Michor Franziska Polyak Kornelia
license: CC-BY 4.0
species: Homo sapiens
studyId: syn7349757
subject: SUM159
ageGroup:
citation: Ge JY et al. (2020). Acquired resistance to combined BET and CDK4/6 inhibition in triple-negative breast cancer. Nat Commun. 11(1):2350. doi: 10.1038/s41467-020-16170-3
dataType: gene expression
keywords: SUM159
accessType: Open Access
contributor:
description: BET inhibitors are promising therapeutic agents for the treatment of triple-negative breast cancer (TNBC), but the rapid emergence of resistance necessitates investigation of combination therapies and their effects on tumor evolution. Here, we show that palbociclib, a CDK4/6 inhibitor, and paclitaxel, a microtubule inhibitor, synergize with the BET inhibitor JQ1 in TNBC lines. High-complexity DNA barcoding and mathematical modeling indicate a high rate of de novo acquired resistance to these ...
grantNumber: CA193461
diseaseFocus:
downloadType: Synapse Hosted
alternateName: GSE131984
manifestation:
specimenCount: 8
yearProcessed: 2019
countryOfOrigin:
individualCount: 8
visualizeDataOn:
dataUseModifiers:
conditionsOfAccess: No restriction
measurementTechnique: RNA-seq single-cell RNA-seq
externalRepositoryUri: geo:GSE131984
includedInDataCatalog:

GSE131984 page is loading…